ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 63 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $151,847,000 | 85.11% |
| Alpha Wave Global, LP | 3,804,328 | $153,086,000 | 8.97% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $165,189,000 | 8.96% |
| Orbimed Advisors | 8,400,768 | $338,047,000 | 2.96% |
| VIKING GLOBAL INVESTORS LP | 19,283,744 | $775,978,000 | 2.13% |
| Baker Brothers Advisors | 10,450,180 | $420,515,000 | 1.58% |
| SB Management Ltd | 6,767,190 | $272,312,000 | 1.54% |
| Logos Global Management LP | 300,000 | $12,072,000 | 1.04% |
| Duquesne Family Office | 659,750 | $26,548,000 | 0.72% |
| Pinz Capital Management, LP | 34,200 | $1,376,000 | 0.62% |
| Foresite Capital Management V, LLC | 20,000 | $805,000 | 0.60% |
| PURA VIDA INVESTMENTS, LLC | 365,000 | $14,688,000 | 0.53% |
| BRANDYWINE MANAGERS, LLC | 8,936 | $360,000 | 0.50% |
| Woodline Partners LP | 431,087 | $17,347,000 | 0.46% |
| Bullseye Asset Management LLC | 17,299 | $695,000 | 0.26% |
| Redmile Group, LLC | 500,000 | $20,120,000 | 0.24% |
| Casdin Capital, LLC | 200,000 | $8,048,000 | 0.24% |
| HHLR ADVISORS, LTD. | 600,000 | $24,144,000 | 0.19% |
| Eventide Asset Management | 300,000 | $12,072,000 | 0.18% |
| Alyeska Investment Group, L.P. | 250,000 | $10,060,000 | 0.14% |
External links
This page lists ABCELLERA BIOLOGICS INC's shareholders in Q4 2020. To view ABCELLERA BIOLOGICS INC's shareholder history, click here.